From: microRNA-mediated regulation of innate immune response in rheumatic diseases
miRNA | Target | Regulated process | References | ||||
---|---|---|---|---|---|---|---|
 | Ligand/cytokine | Receptor | Signaling component | Transcription factor | Others |  |  |
let-7e | Â | TLR4 | Â | Â | Â | Endotoxin sensitivity and tolerance | [53] |
miR-106a | IL-10 | Â | Â | AML1 | Â | Monocyte differentiation, IL-10 production | |
miR-125b | TNFα |  |  |  |  | TNFα production by macrophages | [55] |
miR-142-3p | IL-6 | Â | Â | Â | Â | IL-6 production by DCs | [76] |
miR-145 | Â | Â | MAL | Â | Â | TLR2-mediated and TLR4-mediated signaling | [63] |
miR-146a |  |  | IRAK1, IRAK2, TRAF6 | IRF5, STAT1 |  | NF-κB-mediated inflammatory response, type I interferon induction and signaling | |
miR-148a/b |  |  | CaMKIIα |  |  | DC activation/antigen presentation | [66] |
miR-15 |  |  | IKKα |  |  | Monocyte differentiation | [34] |
miR-152 |  |  | CaMKIIα |  |  | DC activation/antigen presentation | [66] |
miR-155 |  |  | IKKε MyD88 TAB2 | PU.1, C/EBPβ, c-Fos | KPC1 SOCS1 SHIP1 | DC development/maturation granulocyte/monocyte expansion endotoxin sensitivity and tolerance | |
 |  |  |  | BCL6 |  | NF-κB-mediated inflammatory response, AKT signaling and inflammation, type I interferon induction and signaling |  |
miR-155* | Â | Â | Â | Â | IRAKM | Type I interferon induction | [6] |
miR-16 |  |  | IKKα |  |  | Monocyte differentiation | [34] |
miR-17-5p | Â | Â | Â | AML1 | Â | Monocyte differentiation | [32] |
miR-187 |  |  |  | IκBζ |  | IL-10-driven anti-inflammatory response | [71] |
miR-19a/b | Â | TLR2 | Â | Â | Â | TLR2-triggered inflammatory response | [73] |
miR-200b/c |  |  | MyD88 |  |  | NF-κB-mediated inflammatory response | [65] |
miR-20a | Â | Â | Â | AML1 | Â | Monocyte differentiation | [32] |
miR-21 | JAG1 |  |  |  | PDCD4 | DC development/maturation, NF-κB-mediated inflammatory response | |
miR-221 | Â | Â | Â | Â | p27 | DC development/maturation | |
miR-223 |  |  | IKKα, NLRP3 | MEF2C STAT3 |  | Monocyte differentiation, granulocyte proliferation/activation, TLR-induced IL-6/IL-1β production | |
 |  |  |  |  |  | NLRP3 inflammasome response |  |
miR-23b |  |  | TAB2, TAB3, IKKα |  |  | IL-17-triggered, TNFα-triggered, and IL-1β-triggered inflammatory response | [67] |
miR-29 | IFNγ |  |  |  |  | IFNγ production and NK cell activation | [78] |
miR-34a | JAG1 | Â | Â | Â | Â | DC development/maturation | [35] |
 | WNT1 |  |  |  |  |  |  |
miR-424 | Â | Â | Â | NFI-A | Â | Monocyte differentiation | [33] |
miR-9 |  |  |  | NFKB1 |  | NF-κB-mediated inflammatory response | [70] |